Literature DB >> 10340238

Serum cholesterol decline and depression in the postpartum period.

R M van Dam1, A J Schuit, E G Schouten, H L Vader, V J Pop.   

Abstract

We examined the relation between total serum cholesterol decline and depression in the postpartum period in a prospective study of 266 Dutch women, who were followed until 34 weeks after delivery. The decline in serum cholesterol between week 32 of pregnancy and week 10 postpartum was similar for women who became depressed (n = 63) in the subsequent period and women who did not (difference, 0.10 mmol/l; 95% confidence interval [CI] -0.16 to 0.37). Adjusting for age, multiparity, education level, smoking status, concurrent illness, and social support, the odds ratio of depression was 1.4 (95% CI, 0.64 to 2.9) for women in the highest tertile of serum cholesterol decline and 0.61 (95% CI, 0.28 to 1.3) for women in the intermediate tertile, as compared with women in the lowest tertile. Our results do not support the hypothesis that rapid serum cholesterol decline increases risk of depression in the postpartum period.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10340238     DOI: 10.1016/s0022-3999(98)00100-7

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  3 in total

1.  Cholesterol quandaries: relationship to depression and the suicidal experience.

Authors:  Randy A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2008-03

2.  Change in cholesterol level during pregnancy and risk of postpartum depressive symptoms: the Japan Environment and Children's Study (JECS).

Authors:  Norikazu Mutsuda; Kei Hamazaki; Kenta Matsumura; Akiko Tsuchida; Haruka Kasamatsu; Hidekuni Inadera
Journal:  Acta Psychiatr Scand       Date:  2022-01-23       Impact factor: 7.734

3.  How do lipids influence risk of violence, self-harm and suicidality in people with psychosis? A systematic review.

Authors:  Piyal Sen; Danielle Adewusi; Alexandra I Blakemore; Veena Kumari
Journal:  Aust N Z J Psychiatry       Date:  2021-07-09       Impact factor: 5.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.